ALT has been in the news 563% more than usual
Aug 09, 2024, 2:32 PM
-1.74%
What does ALT do
Altimmune, Inc., a clinical stage biopharmaceutical company based in Gaithersburg, Maryland, focuses on developing peptide-based treatments for obesity and liver diseases and has subsidiaries globally. Its leading products, pemvidutide and HepTcell, are undergoing Phase II clinical trials in multiple countries for various indications.
ALT has been in the news recently: Altimmune, Inc. reported positive results from its Phase 2b trial of pemvidutide, indicating up to 15.6% weight loss and significant lipid reductions for metabolic diseases. The company faces competition in the expanding GLP-1 market, which is expected to reach $100 billion by 2030, while its product may draw interest from major players like Novo Nordisk and Eli Lilly.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.